Xiaolan Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiaolan Zhu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Yuefeng Li
School of Medicine, Jiangsu University, Zhenjiang, China
5 shared publications Yan Zhu
Department of Radiology, Affiliated Hospital of Jiangsu University, Zhenjiang, China
4 shared publicationsJinchuan Yan
Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, China
3 shared publicationsJiasheng Qin
Department of Radiology, Affiliated Hospital of Jiangsu University, Zhenjiang, China
2 shared publicationsNingning Zhang
Department of Radiology, Affiliated Hospital of Jiangsu University, Zhenjiang, China
2 shared publications- Shenghong Ju
Department of Radiology, Zhongda Affiliated Hospital of Southeast University, Nanjing, China
2 shared publications
Latest Publications
- 28 May 2022
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (8) , 2845-2857
The predictive value of renal parenchymal information for renal function impairment in patients with ADPKD: a multicenter prospective study
Objective Although the guideline indicates that total kidney volume (TKV) is an important detection indicator in patients with autosomal dominant polycystic kidney disease (ADPKD), this study attempted to demonstrate that renal parenchymal information, combined with parenchymal volume and radiomics features, may have more valuable clinical guiding significance. Methods A totals of 340 ADPKD patients with normal renal function were prospectively collected and followed-up for five years, with renal function tests and non-contrast computed tomography (CT) performed every six months. The relationship between renal function impairment and renal parenchymal volume (RPV) as along with radiomics features was explored using a multiple linear regression model and multiple logistic regression. Then, a combined model of RPV with radiomics features was constructed to comprehensively evaluate its predictive value. Results Compared with TKV, decreased RPV presented a closer relationship with renal function impairment, namely, with the impairment rate (RPV: 82.3% vs. TVK: 67.1%) and eGFR (RPV: r = 0.614, p < 0.001 vs. TKV: r = -0.452, p < 0.001), and showed higher predictive power (RPV: AUC = 0.752 [95%CI 0.692–0.805], p < 0.001 vs. TKV: AUC = 0.711 [95%CI 0.649–0.768], p < 0.001). Correspondingly, the radiomics analysis that was derived from the renal parenchyma also showed a satisfactory result (AUC = 0.849 [95%Cl 0.797–0.892], p < 0.001). Importantly, the predictive power for renal function impairment was further improved in the combined model of RPV and radiomics features (AUC = 0.902 [95%Cl 0.857–0.937], p < 0.001). Conclusion Renal parenchyma information may be a sensitive biomarker of renal function impairment in ADPKD, which can provide a new approach for clinically monitoring renal function, and may greatly improve the pre-hospital prevention and treatment effects. Graphical abstract
- 28 May 2022
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (8) , 2845-2857
The predictive value of renal parenchymal information for renal function impairment in patients with ADPKD: a multicenter prospective study
Objective Although the guideline indicates that total kidney volume (TKV) is an important detection indicator in patients with autosomal dominant polycystic kidney disease (ADPKD), this study attempted to demonstrate that renal parenchymal information, combined with parenchymal volume and radiomics features, may have more valuable clinical guiding significance. Methods A totals of 340 ADPKD patients with normal renal function were prospectively collected and followed-up for five years, with renal function tests and non-contrast computed tomography (CT) performed every six months. The relationship between renal function impairment and renal parenchymal volume (RPV) as along with radiomics features was explored using a multiple linear regression model and multiple logistic regression. Then, a combined model of RPV with radiomics features was constructed to comprehensively evaluate its predictive value. Results Compared with TKV, decreased RPV presented a closer relationship with renal function impairment, namely, with the impairment rate (RPV: 82.3% vs. TVK: 67.1%) and eGFR (RPV: r = 0.614, p < 0.001 vs. TKV: r = -0.452, p < 0.001), and showed higher predictive power (RPV: AUC = 0.752 [95%CI 0.692–0.805], p < 0.001 vs. TKV: AUC = 0.711 [95%CI 0.649–0.768], p < 0.001). Correspondingly, the radiomics analysis that was derived from the renal parenchyma also showed a satisfactory result (AUC = 0.849 [95%Cl 0.797–0.892], p < 0.001). Importantly, the predictive power for renal function impairment was further improved in the combined model of RPV and radiomics features (AUC = 0.902 [95%Cl 0.857–0.937], p < 0.001). Conclusion Renal parenchyma information may be a sensitive biomarker of renal function impairment in ADPKD, which can provide a new approach for clinically monitoring renal function, and may greatly improve the pre-hospital prevention and treatment effects. Graphical abstract
- Top Cited PapersOpen Access
- 9 March 2022
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 20 (1) , 1-17
Neuron secrete exosomes containing miR-9-5p to promote polarization of M1 microglia in depression
Background: Neuroinflammation is an important component mechanism in the development of depression. Exosomal transfer of MDD-associated microRNAs (miRNAs) from neurons to microglia might exacerbate neuronal cell inflammatory injury. Results: By sequence identification, we found significantly higher miR-9-5p expression levels in serum exosomes from MDD patients than healthy control (HC) subjects. Then, in cultured cell model, we observed that BV2 microglial cells internalized PC12 neuron cell-derived exosomes while successfully transferring miR-9-5p. MiR-9-5p promoted M1 polarization in microglia and led to over releasing of proinflammatory cytokines, such as interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which exacerbated neurological damage. Furthermore, we identified suppressor of cytokine signaling 2 (SOCS2) as a direct target of miR-9-5p. Overexpression of miR-9-5p suppressed SOCS2 expression and reactivated SOCS2-repressed Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) pathways. Consistently, we confirmed that adeno-associated virus (AAV)-mediated overexpression of miR-9-5p polarized microglia toward the M1 phenotype and exacerbated depressive symptoms in chronic unpredictable mild stress (CUMS) mouse mode. Conclusion: MiR-9-5p was transferred from neurons to microglia in an exosomal way, leading to M1 polarization of microglia and further neuronal injury. The expression and secretion of miR-9-5p might be novel therapeutic targets for MDD. Graphical
- 9 March 2022
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 20 (1) , 1-17
Top Cited PapersOpen AccessNeuron secrete exosomes containing miR-9-5p to promote polarization of M1 microglia in depression
Background: Neuroinflammation is an important component mechanism in the development of depression. Exosomal transfer of MDD-associated microRNAs (miRNAs) from neurons to microglia might exacerbate neuronal cell inflammatory injury. Results: By sequence identification, we found significantly higher miR-9-5p expression levels in serum exosomes from MDD patients than healthy control (HC) subjects. Then, in cultured cell model, we observed that BV2 microglial cells internalized PC12 neuron cell-derived exosomes while successfully transferring miR-9-5p. MiR-9-5p promoted M1 polarization in microglia and led to over releasing of proinflammatory cytokines, such as interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which exacerbated neurological damage. Furthermore, we identified suppressor of cytokine signaling 2 (SOCS2) as a direct target of miR-9-5p. Overexpression of miR-9-5p suppressed SOCS2 expression and reactivated SOCS2-repressed Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) pathways. Consistently, we confirmed that adeno-associated virus (AAV)-mediated overexpression of miR-9-5p polarized microglia toward the M1 phenotype and exacerbated depressive symptoms in chronic unpredictable mild stress (CUMS) mouse mode. Conclusion: MiR-9-5p was transferred from neurons to microglia in an exosomal way, leading to M1 polarization of microglia and further neuronal injury. The expression and secretion of miR-9-5p might be novel therapeutic targets for MDD. Graphical
- 1 February 2022
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 7 (2) , 162-170
Mediation on the Association Between Stressful Life Events and Depression by Abnormal White Matter Microstructures
- 1 February 2022
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 7 (2) , 162-170
Mediation on the Association Between Stressful Life Events and Depression by Abnormal White Matter Microstructures
- 4 July 2019
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 40 (1) , 54-66
Increased ASL-CBF in the right amygdala predicts the first onset of depression in healthy young first-degree relatives of patients with major depression
Healthy first-degree relatives of patients with major depression are at an elevated risk of developing depression, and regional cerebral blood flow (CBF) alterations are observed in patients with depression. Therefore, in a 33-month follow-up study, we used arterial spin labeling-magnetic resonance imaging (ASL-MRI) to investigate quantitative CBF before and after the diagnosis of depression in healthy young adults with and without first-degree relatives with major depression (FH + and FH−, respectively). In cross-sectional and longitudinal CBF comparisons, CBF in the right amygdala was increased or decreased. Additionally, a significant correlation was observed between the altered CBF in the right amygdala and the scores on the 17-item Hamilton Depression Rating Scale (HDRS) in the FH + group. Furthermore, logistic regression and receiver operating characteristic curve analyses showed that increased CBF in the right amygdala at baseline predicted the subsequent onset of depression in the FH + group. Our results suggest that among healthy young adults with a familial risk of depression, those who exhibit increased CBF in the amygdala are susceptible to developing this disease.
- 4 July 2019
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 40 (1) , 54-66
Increased ASL-CBF in the right amygdala predicts the first onset of depression in healthy young first-degree relatives of patients with major depression
Healthy first-degree relatives of patients with major depression are at an elevated risk of developing depression, and regional cerebral blood flow (CBF) alterations are observed in patients with depression. Therefore, in a 33-month follow-up study, we used arterial spin labeling-magnetic resonance imaging (ASL-MRI) to investigate quantitative CBF before and after the diagnosis of depression in healthy young adults with and without first-degree relatives with major depression (FH + and FH−, respectively). In cross-sectional and longitudinal CBF comparisons, CBF in the right amygdala was increased or decreased. Additionally, a significant correlation was observed between the altered CBF in the right amygdala and the scores on the 17-item Hamilton Depression Rating Scale (HDRS) in the FH + group. Furthermore, logistic regression and receiver operating characteristic curve analyses showed that increased CBF in the right amygdala at baseline predicted the subsequent onset of depression in the FH + group. Our results suggest that among healthy young adults with a familial risk of depression, those who exhibit increased CBF in the amygdala are susceptible to developing this disease.
- 1 March 2018
- Published by Elsevier in Brain Research Bulletin
- Vol. 137, 91-97
Increased hippocampal fissure width is a sensitive indicator of rat hippocampal atrophy
- 1 March 2018
- Published by Elsevier in Brain Research Bulletin
- Vol. 137, 91-97
Increased hippocampal fissure width is a sensitive indicator of rat hippocampal atrophy
- 25 September 2017
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 23 (11) , 907-916
Fibroblast growth factor 22 is a novel modulator of depression through interleukin‐1β
Summary: Background and Aims: Emerging evidence shows that fibroblast growth factor 22 (FGF22) plays a critical role in the etiology of depression. However, the molecular mechanisms of FGF22 are not fully comprehended. Here, the effect of FGF22 in depression and its relationship with interleukin‐1β (IL‐1β) were investigated in clinical, animal, and cell experiments.Methods: Serum from depressive patients was collected, and the levels of FGF22 and IL‐1β were analyzed by ELISA. The chronic unpredictable mild stress (CUMS) model was established, and primary hippocampal neuronal cells were cultured to examine changes in FGF22 and IL‐1β levels in rat hippocampus.Results: The results revealed a negative correlation between serum FGF22 levels and serum IL‐1β levels. The expression of IL‐1β in the CUMS rat hippocampus decreased, and the apoptosis of hippocampal cells improved after the injection of lentiviral vector‐mediated FGF22 (LV‐FGF22). Further tests in primary hippocampal neuronal cells also showed a reduction in IL‐1β and the cell apoptosis rate after treatment with FGF22.Conclusion: In conclusion, the results revealed that FGF22 plays a role in alleviating depression, which may be mediated by reduced expression of IL‐1β.
- 25 September 2017
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 23 (11) , 907-916
Fibroblast growth factor 22 is a novel modulator of depression through interleukin‐1β
Summary: Background and Aims: Emerging evidence shows that fibroblast growth factor 22 (FGF22) plays a critical role in the etiology of depression. However, the molecular mechanisms of FGF22 are not fully comprehended. Here, the effect of FGF22 in depression and its relationship with interleukin‐1β (IL‐1β) were investigated in clinical, animal, and cell experiments.Methods: Serum from depressive patients was collected, and the levels of FGF22 and IL‐1β were analyzed by ELISA. The chronic unpredictable mild stress (CUMS) model was established, and primary hippocampal neuronal cells were cultured to examine changes in FGF22 and IL‐1β levels in rat hippocampus.Results: The results revealed a negative correlation between serum FGF22 levels and serum IL‐1β levels. The expression of IL‐1β in the CUMS rat hippocampus decreased, and the apoptosis of hippocampal cells improved after the injection of lentiviral vector‐mediated FGF22 (LV‐FGF22). Further tests in primary hippocampal neuronal cells also showed a reduction in IL‐1β and the cell apoptosis rate after treatment with FGF22.Conclusion: In conclusion, the results revealed that FGF22 plays a role in alleviating depression, which may be mediated by reduced expression of IL‐1β.
- 1 September 2017
- Published by Elsevier in Journal of Affective Disorders
- Vol. 219, 17-24
Dilated Virchow–Robin spaces in the hippocampus impact behaviors and effects of anti-depressant treatment in model of depressed rats
- 1 September 2017
- Published by Elsevier in Journal of Affective Disorders
- Vol. 219, 17-24
Dilated Virchow–Robin spaces in the hippocampus impact behaviors and effects of anti-depressant treatment in model of depressed rats